Lesson 7 of 10 · 15 min
The placebo effect
Explain the placebo effect, and why treatment trials use a placebo group, random allocation and single-blind or double-blind procedures.
What you will be able to do
- Explain the placebo effect and the nocebo effect.
- Explain why a treatment trial needs a placebo group and a no-treatment group.
- Distinguish single-blind and double-blind procedures and explain what each controls.
Give people a sugar pill and tell them it is a new medication for anxiety, and many will report feeling calmer. Some will show measurable changes too. Nothing in the pill can do that. The improvement comes from the person's expectation that they are being treated.
Definition
The placebo effect
A placebo is an inactive substance or procedure made to look like the real treatment, such as a sugar pill or a saline injection. The placebo effect is an improvement in a person's condition that occurs because they believe they are receiving an effective treatment, not because of any active ingredient.
Why does it happen? Research points to several processes:
- Expectation. Believing a treatment will work changes how a person feels and what they notice. It can reduce anxiety and pain, and it changes activity in the brain (expecting relief can release the body's own opioids and dopamine).
- Conditioning. After years of taking tablets that worked, the look and ritual of treatment (a pill, a doctor's room) can become conditioned stimuli that trigger improvement on their own.
- Care and attention. Being seen, listened to and looked after by a health professional is itself reassuring.
The effect also works in reverse. In the nocebo effect, a person who expects side effects or harm reports them, even from an inactive substance.
Which is the best description of the placebo effect?
Why trials need a placebo group. Suppose people with GAD take a new medication for eight weeks and their anxiety scores fall. Three things could have caused it: the medication, the placebo effect, and changes that would have happened anyway (people often seek treatment at their worst, and many improve with time). A good trial separates them with three groups:
- a treatment group that receives the real medication
- a placebo group that receives an identical-looking inactive pill
- a no-treatment (waiting-list) group that receives nothing during the trial.
| Comparison | What the difference measures |
|---|---|
| Placebo minus no treatment | The placebo effect: improvement from expecting to be treated |
| Treatment minus placebo | The treatment effect: what the active ingredient adds |
| Treatment minus no treatment | Both together: the active ingredient and the placebo effect |
| The no-treatment group's own change | Natural recovery and other changes over time |
Worked example
Identify the placebo effect in a trial
In a fictional trial of a new tablet for specific phobia of spiders, fear ratings (0–100) fell by a mean of 30 points in the tablet group, 18 points in the placebo group and 5 points in the no-treatment group.
(a) Calculate the placebo effect and the treatment effect. (b) Explain what the placebo group's result shows.
Step 1: Placebo effect
Placebo no treatment points.
Step 2: Treatment effect
Tablet placebo points.
Subtracting the placebo group removes both natural change and the placebo effect, leaving what the active ingredient added.
Step 3: Explain the placebo result
The placebo group improved 13 points more than the no-treatment group although their tablet had no active ingredient. The extra improvement came from expecting to be treated: the placebo effect.
Try it yourself first, then check the working one step at a time.
Answer
(a) Placebo effect 13 points; treatment effect 12 points. (b) Expectation alone reduced fear by 13 points more than no treatment, so a large part of the tablet group's 30-point improvement was not caused by the active ingredient.
Method
Placebo effect = placebo − no treatment.
Treatment effect = treatment − placebo.
Interpret each difference in words, with units.
Watch out for
Giving 25 points (tablet − no treatment) as the treatment effect: it includes the placebo effect.
Blinding. A placebo only controls expectations if participants cannot tell which group they are in.
- In a single-blind procedure, the participants do not know whether they receive the treatment or the placebo. This controls participant expectations.
- In a double-blind procedure, neither the participants nor the researchers who give the treatment and measure the outcomes know. This also controls experimenter expectancy: a researcher who knows who got the real drug might, without meaning to, encourage those participants more or rate their symptoms more kindly.
Someone not involved in running the trial holds the code that says who is in which group, and it is revealed only after the results are recorded. Participants are also randomly allocated to groups, so differences between people (how severe their anxiety is, their age, their expectations) are spread evenly.
A fictional trial of an eight-week mindfulness program for stress. Switch controls on and watch which threats each one removes.
In a trial of a new anxiety medication, the participants do not know whether they are taking the medication or a placebo, but the psychologist who rates their anxiety each week does know. What kind of procedure is this, and what problem remains?
Illustrative data. With no blinding and self-chosen groups, the treatment looks better than it is. Switch on random allocation and double-blinding and compare.
Worked example
Evaluate and improve a treatment trial
A fictional clinic wants to show that its new relaxation app reduces anxiety. Forty clients with GAD choose whether to use the app for six weeks; 20 do and 20 don't. The clinic's psychologist, who designed the app, rates every client's anxiety before and after. App users improve by a mean of 9 points and non-users by 3 points, and the clinic claims the app "reduces anxiety by 6 points".
Evaluate the clinic's claim and propose an improved design. (6 marks)
Step 1: Identify the allocation problem
Clients chose their own group. People who choose an app may be more motivated or less severely anxious, a participant variable that could cause the difference instead of the app. Random allocation would spread these differences evenly.
Step 2: Identify the placebo problem
App users knew they were being treated and non-users knew they were not, so part of the 6-point difference could be the placebo effect. A placebo condition (an app that looks similar but has no relaxation training) would separate it.
Step 3: Identify the experimenter problem
The rater designed the app and knew who used it, so experimenter expectancy could bias the ratings. A rater who does not know the groups (a double-blind procedure with a placebo app) would control it.
Step 4: Judge the claim
Because of these confounds, the 6 points cannot be attributed to the app: the claim is not supported.
Step 5: Propose the improved design
Randomly allocate the 40 clients to three groups: the real app, a placebo app and a waiting list. Keep participants and the rater blind to the app condition, use a standardised rating scale, and compare real app with placebo app using an unpaired t-test.
Try it yourself first, then check the working one step at a time.
Answer
The claim is not supported: self-selection (a participant confound), no placebo control (expectations) and a non-blind rater who designed the app (experimenter expectancy) could each explain the difference. An improved trial randomly allocates clients to a real app, a placebo app and a waiting list, double-blind for the two app groups, and tests real against placebo.
Method
Look for problems with allocation, expectations and who measures the outcome.
Say how each could produce the result without the treatment working.
Make a judgement about the claim.
Propose a design that fixes each problem.
Watch out for
Suggesting "a larger sample" as the only improvement: it improves reliability but not the confounds.
Note
Ethics of placebo trials
Giving a placebo means some participants go without an active treatment for a while. Ethical guidelines allow it only where it does not expose people to serious harm, and participants give informed consent knowing they may receive a placebo, without knowing which. Where an effective treatment already exists, a new treatment is often compared with it instead of with a placebo. Participants can withdraw at any time, and are debriefed and offered effective treatment after the trial.
Common mistake
Calling the placebo effect "fake"
The improvement is real; what is missing is an active ingredient. And the placebo effect is not the same as natural recovery: the no-treatment group shows natural recovery, and the placebo group shows natural recovery plus the placebo effect.
Summary
The placebo effect is a real improvement caused by believing you are receiving an effective treatment; the nocebo effect is harm caused by expecting it.
It works through expectation, conditioning and the care that comes with treatment.
A three-group trial separates the placebo effect (placebo minus no treatment) from the treatment effect (treatment minus placebo).
Single-blind: participants don't know their group. Double-blind: participants and researchers don't know.
Random allocation spreads participant differences; informed consent, withdrawal and debriefing keep placebo trials ethical.
Finished the lesson?
Try the 2 quick checks above and the lesson completes itself, or mark it complete now.